NEW YORK, Jan. 28, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Avantor, Inc. (NYSE: AVTR) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Avantor...
RADNOR, Pa., Jan. 5, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Emmanuel Ligner, President and CEO, will present at the 44th...
NEW YORK--(BUSINESS WIRE)---- $AVTR #AVTR--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) and reminds investors of the December 29, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has
NEW YORK--(BUSINESS WIRE)---- $AVTR #AVTR--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) and reminds investors of the December 29, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has
LOS ANGELES, Dec. 11, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Avantor, Inc. ("Avantor " or "the Company") (NYSE: AVTR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by...
NEW YORK, Dec. 7, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the "Class Period"), of the important December 29, 2025 lead...
NEW YORK, Dec. 2, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the "Class Period"), of the important December 29, 2025 lead...
NEW YORK--(BUSINESS WIRE)---- $AVTR #classactionlawsuit--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE:AVTR) securities during the period of March 5, 2024 through October 28, 2025, inclusive (“the Class Period”). If you suffered a loss on your Avantor investments, you have until December 29, 2025 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFERED A LOSS]
SAN DIEGO, Dec. 1, 2025 /PRNewswire/ -- Company: Avantor, Inc. (NYSE: AVTR) provides scientific products and services for customers in biotechnology, pharmaceuticals, healthcare, education, government, and other industries. What is the class period? March 5, 2024 - October 28, 2025 What...
NEW YORK, Nov. 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Avantor, Inc. (NYSE: AVTR). Shareholders who purchased shares of AVTR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment....
RADNOR, Pa., Nov. 19, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the opening of its newest Centralized Service Center (CSC)...
NEW YORK, Nov. 18, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the "Class Period"), of the important December 29, 2025 lead...
SAN DIEGO, Nov. 7, 2025 /PRNewswire/ -- Company: Avantor, Inc. (NYSE: AVTR) provides scientific products and services for customers in biotechnology, pharmaceuticals, healthcare, education, government, and other industries. Class Period: March 5, 2024 - October 28, 2025 The Case: Robbins...
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming December 29, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AVANTOR, INC. (AVTR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SE
Emmanuel Ligner, Seasoned Leader with Proven Track Record of Value Creation in Life Sciences, to Begin Role as CEO Next Week RADNOR, Pa., Aug. 11, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life...
NEW YORK--(BUSINESS WIRE)--Engine Capital LP (together with its affiliates, “Engine” or “we”), which owns approximately 3% of the outstanding shares of Avantor, Inc. (NYSE: AVTR) (“Avantor” or the “Company”), today sent a letter to the Company’s Board of Directors outlining several opportunities to close Avantor’s significant valuation gap and unlock value for shareholders. The letter can be viewed and downloaded here. About Engine Capital Engine Capital LP is a value-oriented special situation
Avantor missed Q1 sales estimates and faced multiple analyst downgrades as concerns mount over growth, competition, and product performance.
Avantor matched EPS expectations but missed revenue targets and cut its outlook as its CEO steps down and cost-saving plans ramp up.
Repligen reported Q4 EPS of $0.44, beating estimates, with revenue of $167.55 million. The company projects 2025 sales of up to $710 million as the market recovers.
Quantum-Si partners with NVIDIA to advance AI-powered proteomics, collaborates with Avantor for U.S. and Canada distribution of protein sequencing tech.
Barclays raised the price target on Starbucks Corporation (NASDAQ: SBUX) from $96 to $100. Barclays analyst Jeffrey Bernstein maintained the stock with an Overweight rating. Starbucks shares rose 1.6% to $89.21 in pre-market trading.
Within the last quarter, Avantor (NYSE:AVTR) has observed the following analyst ratings:
Avantor (NYSE:AVTR) has observed the following analyst ratings within the last quarter:
Over the past 3 months, 9 analysts have published their opinion on Avantor (NYSE:AVTR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
